TransMedics Group (TMDX) Tops Q1 EPS by 44c ; Offers Guidance

TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of $0.70, $0.44 better than the analyst estimate of $0.26. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $123.66 million.

GUIDANCE:

TransMedics Group sees FY 2025 revenue of $565-585 million, versus the consensus of $540.5 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
• General Mills beats estimates as cost savings offset volumes
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance